SEP 27, 2016 05:50 PM PDT

Iron Nanoparticles Reign in the Immune Attack on Cancer

WRITTEN BY: Kara Marker
Scientists from Stanford University accidentally discovered a new cancer treatment, and it’s got all of the anti-cancer capabilities of chemotherapy without any of the toxic side effects. 
Researchers were studying the potential of iron nanoparticles to deliver chemotherapy into mice with tumors when they realized that the nanoparticles alone had anti-cancer properties. The original experimental group of mice received nanoparticles packed with chemotherapy, to be compared to two control groups: mice receiving “empty” nanoparticles with no chemotherapy and mice receiving neither nanoparticles nor chemotherapy.

Their results showed a reduction in tumor growth in mice that received the empty nanoparticles compared to the other control group, and the researchers realized that they had inadvertently discovered anti-cancer properties of iron nanoparticles. 

Iron nanoparticles already exist as FDA-approved iron supplements that are commercially available as “ferumoxytol.” They are currently used as an injection to treat iron-deficiency anemia in adults with chronic kidney disease, working to restore iron levels so the body can make more red blood cells. However, as seen in the present study, researchers like senior author Heike Daldrup-Link, MD, are realizing that iron nanoparticles “may have hidden intrinsic effects that we won't appreciate unless we look at the nanoparticles themselves."

After the researchers initially realized the anti-cancer ability of ferumoxytol, they conducted further studies to get a clearer picture of how the nanoparticles were reducing tumor growth. They found that ferumoxytol prompts tumor-associated macrophages (TAMs) to destroy cancer cells in mice, and they believe that it works the same way in human as well.

While TAMs are already designed to contain anti-cancer abilities, but large tumors can inhibit their activity. Iron nanoparticles work by rebooting the ability of TAMs to recognize and attack cancer cells. In fact, without TAMs, nanoparticles would have no anti-cancer qualities. 

The researchers continued with studies of mice models of both breast cancer and small-cell lung cancer, proving respectively that one dose of ferumoxytol inhibits tumor growth for up to three weeks and limits metastasis in the liver.  

Because ferumoxytol is already approved by the FDA, the transition from animal studies to human clinical trials is likely to be speedier than normal. Ferumoxytol has the potential to complement existing cancer treatments such as immunotherapy, radiation, chemotherapy, and surgery. Plus, since the iron nanoparticles lack the toxic side effects present during chemotherapy, they could be used to treat patients in the vulnerable period after surgery to remove tumor masses.

"We think this could bridge the time when the patient is quite sick after surgery, and help keep the cancer from spreading until they are able to receive chemotherapy," Daldrup-Link said. "If there are some tumor cells left after surgery, it might work to inject iron nanoparticles there, and the smaller tumor seeds could potentially be taken care of by our immune system.”

The study was recently published in the journal Nature Nanotechnology
 


Sources: Stanford University School of Medicine, MedlinePlus
Image: Amy Thomas
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 22, 2018
Cell & Molecular Biology
JUL 22, 2018
Using Nanosubmarines to Fight Tumors and Headaches
Researchers are getting closer to creating targeted therapies that are delivered directly where needed....
OCT 09, 2018
Drug Discovery
OCT 09, 2018
'Copper Antibiotic Peptide' Effective in Eradicating Tuberculosis
The bacterium responsible for Tuberculosis has found a way to avoid antibiotics by hiding inside the macrophages which are the specific immune cells that a...
OCT 11, 2018
Cell & Molecular Biology
OCT 11, 2018
Revealing a 'Double Agent' in the Immune System
Researchers want to enhance our natural defenses to fight a variety of health problems more effectively....
OCT 31, 2018
Immunology
OCT 31, 2018
Masking the Pathogen
Researchers at Penn State have revealed bacterial pathogens capable of creating components used for DNA replication without the use of metal ions allowing them to evade the immune system...
NOV 05, 2018
Drug Discovery
NOV 05, 2018
Anti-Parasitic Drug Improves Long-term Clinical Outcomes in Chagas Disease
In a recent study published in PLOS Neglected Tropical Diseases, an anti-parasite drug by the name of ‘benznidazole’ may hold potential in impr...
NOV 14, 2018
Immunology
NOV 14, 2018
Stress in Youth Can Mean Depression as an Adult
A research team investigates early life stress and its relation to adult depression and anxiety...
Loading Comments...